155 related articles for article (PubMed ID: 12467943)
1. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
[TBL] [Abstract][Full Text] [Related]
2. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
[TBL] [Abstract][Full Text] [Related]
3. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
Cleare AJ; Forsling M; Bond AJ
Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
[TBL] [Abstract][Full Text] [Related]
5. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.
Sevy S; Brown SL; Wetzler S; Kotler M; Molcho A; Plutchik R; van Praag HM
Psychiatry Res; 1994 Sep; 53(3):219-29. PubMed ID: 7870844
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
[TBL] [Abstract][Full Text] [Related]
7. The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers.
Silverstone PH; Rue JE; Franklin M; Hallis K; Camplin G; Laver D; Cowen PJ
Int Clin Psychopharmacol; 1994 Sep; 9(3):173-8. PubMed ID: 7814826
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
[TBL] [Abstract][Full Text] [Related]
9. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF
Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
[TBL] [Abstract][Full Text] [Related]
11. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression.
Cleare AJ; Bond AJ
Psychopharmacology (Berl); 2000 Mar; 148(4):344-9. PubMed ID: 10928305
[TBL] [Abstract][Full Text] [Related]
12. Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder.
Goddard AW; Woods SW; Money R; Pande AC; Charney DS; Goodman WK; Heninger GR; Price LH
Psychiatry Res; 1999 Mar; 85(3):225-40. PubMed ID: 10333376
[TBL] [Abstract][Full Text] [Related]
13. Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory.
Moeller FG; Allen T; Cherek DR; Dougherty DM; Lane S; Swann AC
Psychiatry Res; 1998 Oct; 81(1):31-8. PubMed ID: 9829648
[TBL] [Abstract][Full Text] [Related]
14. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
Gelfin Y; Lerer B; Lesch KP; Gorfine M; Allolio B
Psychopharmacology (Berl); 1995 Aug; 120(3):356-64. PubMed ID: 8524984
[TBL] [Abstract][Full Text] [Related]
15. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
[TBL] [Abstract][Full Text] [Related]
16. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
Silverstone PH; Cowen PJ
Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
[TBL] [Abstract][Full Text] [Related]
17. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
Meltzer HY; Maes M
Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
[TBL] [Abstract][Full Text] [Related]
18. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
[TBL] [Abstract][Full Text] [Related]
19. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS
Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635
[TBL] [Abstract][Full Text] [Related]
20. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).
Price LH; Malison RT; McDougle CJ; McCance-Katz EF; Owen KR; Heninger GR
Neuropsychopharmacology; 1997 Nov; 17(5):342-50. PubMed ID: 9348549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
